Endothelin-1 can reduce infarct size through protein kinase C and K(ATP) channels in the isolated rat heart

Cardiovascular Research

Volumn 32, Issue 5, 1996, Pages 920-929

  Bugge, Einar ^a   Ytrehus, Kirsti ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

ATP sensitive; endothelin 1; myocardial infarction; myocardial ischemia; potassium channel; protein kinase C; rat; rat, heart

Indexed keywords

BOSENTAN; CHELERYTHRINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKALOIDS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BENZOPHENANTHRIDINES; CORONARY CIRCULATION; DECANOIC ACIDS; ENDOTHELINS; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDES, CYCLIC; PERFUSION; PHENANTHRIDINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; SULFONAMIDES;

EID: 0030296495     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00129-0     Document Type: Article

References (46)

1. [1] Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. [2] Hasdai D, Kornowski R, Battler A. Endothelin and myocardial ischemia. Cardiovasc Drugs Ther 1994;8:589-599.
3. [3] Larkin SW, Clarke JG, Keogh BE, et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 1989;64:956-958.
4. [4] Brunner F, du Toit EF, Opie LH. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol 1992;24:1291-1305.
5. [5] Zaugg CE, Zhu P, Simper D, Luscher TF, Allegrini PR, Buser PT. Differential effects of endothelin-1 on normal and postischemic reperfused myocardium. J Cardiovasc Pharmacol 1993;22(suppl 8):S367-S370.
6. [6] Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction [Letter]. Lancet 1989;2:53-54.
7. [7] Tønnessen T, Naess PA, Kirkebøen KA, Offstad J, Ilebekk A, Christensen G. Endothelin is released from the porcine coronary circulation after short-term ischemia. J Cardiovasc Pharmacol 1993;22(suppl 8):S313-S316.
8. [8] Velasco CE, Turner M, Inagami T, et al. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J 1994;128:441-451.
9. [9] Kusumoto K, Awane Y, Fujiwara S, Watanabe T. Role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 1993;22(suppl 8):S339-S342.
10. [10] Tønnessen T, Giaid A, Saleh D, Naess PA, Yanagisawa M, Christensen G. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 1995;76:767-772.
11. [11] Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991;69:370-377.
12. [12] Wang Q-D, Li X-S, Lundberg JM, Pernow J. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc Res 1995;29:805-812.
13. B receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br J Pharmacol 1995;114:949-954.
14. [14] Grover GJ, Dzwonczyk S, Parham CS. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993;27:1613-1618.
15. B antagonist. Br J Pharmacol 1994;113:869-876.
16. [16] Krause SM, Lynch JJJ, Stabilito II, Woltmann RF. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog. Cardiovasc Res 1994;28:1672-1678.
17. A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br J Pharmacol 1994;112:75-80.
18. [18] Velasco CE, Yanagisawa M, Williamson JL, Triana JF, Cardioprotective action of endothelin-1 during ischemia. Circulation 1993;88(suppl):1-544(Abstract).
19. [19] Downey JM, Cohen MV, Ytrehus K, Liu Y. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann NY Acad Sci 1994;723:82-98.
20. [20] Bugge E, Ytrehus K. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 1995;29:401-406.
21. 6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits. Cardiovasc Res 1993;27:652-656.
22. [22] Thornton JD, Daly JF, Cohen MV, Yang X-M, Downey JM. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 1993;73:649-655.
23. [23] Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effect of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol 1993;25:311-320.
24. [24] Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27:883-892.
25. [25] Bugge E, Ytrehus K. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 1996; in press.
26. [26] Simonson MS, Dunn MJ. Cellular signaling by peptides of the endothelin gene family. FASEB J 1990;4:2989-3000.
27. [27] Wang P, Gallagher K, Downey JM, Cohen MV. Endothelin-1 limits myocardial infarction through PKC activation. J Mol Cell Cardiol 1995;27:A44( Abstract).
28. [28] Hide EJ, Piper J, Thiemermann C. Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol 1995;116:2597-2602.
29. [29] Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-235.
30. A receptor. Life Sci 1992;50:247-255.
31. [31] Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990;172:993-999.
32. [32] McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 1991;69:949-958.
33. [33] Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107-H1112.
34. [34] Hu K, Duan D, Nattel S. Protein kinase C-mediated activation of ATP-sensitive potassium current - the missing link in ischemic preconditioning? Circulation 1995;92(suppl):1-251(Abstract).
35. [35] Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-621.
36. [36] Jones RM, Prasad MR. Enhanced responses to endothelin during perfusion of ischemic myocardium. Am J Cardiovasc Pathol 1992;4:145-156.
37. [37] Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
38. B) mediate vasoconstriction in the perfused rat heart. J Cardiovasc Pharmacol 1993;2(suppl 8):S248-S251.
39. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867-873.
40. A receptor antagonist. J Cardiovasc Pharmacol 1994;24:587-594.
41. ATP channel. Am J Physiol 1994;266:H829-H839.
42. [42] Hoshida S, Kuzuya T, Nishida M, et al. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts. Cardiovasc Res 1994;28:1083-1088.
43. [43] Stauss HM, Zhu YC, Redlich T, et al. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. J Cardiovasc Risk 1994;1:255-262.
44. [44] Hori S, Komatsu Y, Shigemoto R, Mizuno N, Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 1992;130:1885-1895.
45. ATP channels in ischaemic preconditioning. Cardiovasc Res 1994;28:783-787.
46. [46] Hayashida W, Donckier J, van Mechelen H, Stoleru L, Pouleur H. Endothelin-1 exacerbates diastolic stunning in conscious dogs. Am J Physiol 1993;265:H1688-H1695.